Miriam Rogers

• Start up division focusing on dermal tissue used in breast reconstruction and hernia repair
• Call on C-suites, supply chain management, plastic and general surgeons
• Drive sales and regional contracts with strategic partners, Ethicon and Mentor
• Continue to drive sales through contract negotiations encompassing entire portfolio of MTF tissue forms
• Human donated tissue – quantifiable numbers not published for ethical reasons

• Manage direct and strategic partner promotion of human allograft tissue forms used in sports, orthopedic, spine, general and plastic surgery
• Strategic partners include Synthes/DePuy, Orthofix, ConMed Linvatec, Ethicon, Mentor
• Call points include C-suites, supply chain management, multiple hospital departments, and physician offices
• Managed $10 million dollar territory

• Reorg Position: Responsible for training new RSS employees in the field
• First two weeks of a new hire’s orientation and training is managed through the field trainer

• One of 3 in the country to cross-sell two product lines across divisions
• Sold fastest growing disposable breast biopsy products in the market to hospitals and breast imaging centers
• Involves capital sales and training for stereotactic, MRI and ultrasound modalities
• Sold MammoSite Targeted Radiation Therapy for breast cancer patients in radiation oncology suites and surgeon offices in Michigan

Develop and expand business at 3 Michigan institutions with complex structures. Ranked in top 4 territories in the country for last 4.5 years. Field Sales Trainer 2022 to present.

• Immuno-oncology representative in Metro Detroit for the kidney indication

• Develop MI market for a 'next generation' genomic assay for breast cancer via hematology/oncology, surgery, pathology, and related multi-disciplinary teams
• Rank 4th in the country for growth 2016, Century Club 2017 111% to plan, 2018 108% to plan
• Promoted to Senior MOS 12/2018

• 1 of 72 reps nationwide out of 2600+ candidates chosen to launch the newly approved KYBELLA in the aesthetic market
• Manage sales and product growth through education, training and business development in strategic accounts
• Company immediately acquired by ALLERGAN
• Equity position

• Promotion: Manage 3 BTSS reps to work on key accounts in a 3 state region developing High Dose Radiation (HRD) facilities where MammoSite 5-Day Targeted Radiation Therapy can be utilized for early stage breast cancers
• Knowledge required in general/breast surgery, radiation oncology, dosimetry/physics, patient care and reimbursement
• Ranked 3rd in country
• Nominated to President’s Council by peers

• President’s Club Member, Top 5 in Country
• Developed MammoSite Targeted Radiation Therapy programs for breast cancer patients in hospitals and physician offices for Michigan and Northern Indiana